Visit this page frequently for important bulletins, alerts and advisories for Vermont Medicaid enrolled pharmacies.
2023
January
- Preferred Albuterol Sulfate Inhaler Availability - 1.27.23
- Differin Coverage Changes - Effective 1.1.23
- Change to Medicaid Copay - Effective 2.1.23
- Important Information on Reimbursement for High-Investment Carve-Out Drugs
2022
December
- Updates to Buprenorphine Prior Authorization Form - Effective 1.1.23
- Point of Sale (POS) Blackout Period - 12.16.22
- Change Healthcare Observance of Christmas and New Year Hours - 12.14.22
- 2023 Preferred Drug List (PDL) Changes - Effective 1.1.23
- Changes to Select Specialty Pharmacy Medication Dispensing - Effective 01.13.23
- Changes to Coverage for Diabetic Supplies - Effective 1.1.23
November
- Changes to Coverage for Select Outpatient Infusions - Effective 01.01.2023
October
- Pharmacy Newsletter - October 2022
- Synagis Season - Effective 10/10/2022
- Important Changes to Coverage for Naloxone Nasal Spray - Effective 10/7/22
- Buprenorphine Products Covered List -October 1, 2022
September
August
June
- Changes to Vpharm 2 and Vpharm 3 Coverage 6.28.22
- Pharmacy Newsletter 6.28.22
- Blood Glucose Test Strip Quantity Limit 6.7.2022
- Important Changes to Coverage for Etonogestrel/Ethinyl Estradiol Vaginal Ring 6.6.2022
- Point of Sale (POS) Blackout Period 6.3.2022
- Updated Letrozole Prior Authorization Request 6.2.2022
May
- Point of Sale (POS) Blackout Period 5.17.2022
April
March
- Important Information for Treatment Related to COVID-19 – 03/21/2022
- Buprenorphine Products Covered List - 03/18/2022
- Synagis Season Update 2021 to 2022 - 03/8/2022
- Pharmacy Newsletter - 03/02/2022
February
January
- Important Changes to Administration Fee for Vaccines - Effective 1/1/2022
- Update on Pharmacy COVID-19 Antigen Test Coverage - 01/28/22
2021
December
- Preferred Drug List (PDL) Changes - effective 01/01/22
- Pharmacy COVID-19 Antigen Test Coverage -12/16/21
November
- Clozapine REMS Requirements Change - 11/10/2021
- PrEP Medication Copay Waiver - 11/05/2021
October
- Pharmacy Newsletter - 10/29/2021
- Updated Billing Information for COVID-19 Vaccines - 10/14/2021
September
- Changes to Coverage for Continuous Glucose Monitoring (CGM) Systems and Supplies -Effective 10/01/21
- COVID-19 Vaccine Booster Billing - 09/07/2021
- Influenza (Flu) 2021/2022 season - 09/03/2021
- Synagis Atypical 2021 Summer Season - 09/02/2021
August
- COVID-19 Booster Vaccines - August 27, 2021
July
- Updated Age Edits for Codeine Pain and Cough Medication - Effective July 30, 2021
- Team Care Program- July23, 2021
- Pharmacist-Provided Tobacco Cessation services - Effective July 1, 2021
June
- Reminder: Vermont Medicaid Billing with Closed Primary Commerical Insurance - June 25, 2021
- Important Notice: Point of Sale (POS) Blackout Period - June 18, 2021
- Important Update on Hepatitis C Direct Acting Antivirals (DAAs) - June 15, 2021
- Important Notice: Point of Sale (POS) Blackout Period - June 14, 2021
May
April
- Important Information on Cumulative MME Limits - 04/28/21
- Important New Coverage of Omnipod DASH Insulin Pump - Effective 4/1/2021
March
February
January
- Pharmacy Newsletter 1/21/21
2020
December
- Information on COVID-19 Prior Authorization Extensions - 12/29/2020
- Changes to Coverage for Taltz - 12/28/2020
- Important Billing Information for COVID-19 Vaccines - 12/24/2020
- Preferred Drug List (PDL) January 1, 2021 Changes
- Additional Information on Pharmacist Enrollment for COVID-19 Vaccine Administration - 12/17/2020
- Changes to Preferred Albuterol Inhalers - 12/15/2020
- Pharmacist Enrollment Required for Reimbursement of COVID-19 Vaccine Administration 12/11/2020
November
- Attention Pharmacies and Pharmacists - Administration of Vaccines to Children 3-18 Years of Age 11/16/2020
October
- Smoking Cessation - 10/20/20
September
August
- Influenza (Flu) 2020/2021 Season Provider Notification
- Important Changes to Buprenorphine/Naloxone Tablets PDL Status - Effective 08/21/2020
July
- Important Update on Early Refill Overrides with Submission Clarification Code (SCC)=13 - Effective 7/24/2020
June
- Point of Sale (POS) Blackout Period Wednesday June 24,2020 - June 22, 2020
- Attention Pharmacies - Important Information about the DVHA Team Care Program - June 17, 2020
April
- Extension of Prior Authorizations - Response to the COVID-19 Emergency - effective 5/1/2020
- IMPORTANT: Discount Card Reminder
- Reminder to DME providers and Prescribers: Continuous Glucose Monitors (CGM) PA Waived
March
- Covid-19 Update - Effective 3/27/2020
- Important Pharmacy Information in Response to COVID-19
- COVID-19 - Retail Pharmacy Home Delivery Options - last updated 3/30/2020
January
- Changes to Refill Tolerance for Controlled Substances - Effective 01/09/2020
2019
December
- Preferred Drug List (PDL) Changes - Effective 01/01/2020
- Important Change to Medicare Claim Submission - Effective 01/01/2020
- Pharmacy Benefit Programs Provider Satisfaction Survey
November
- Pharmacy Newsletter
- Changes to Refill Limits - effective 11/01/2019
- Changes to Administration Fee for Vaccines - effective 11/08/19
October
- DVHA Preferred Drug List (PDL) - effective 10/11/2019
- Changes to Coverage for Continuous Glucose Monitoring (CGM) Systems and Supplies - Effective 10/1/2019
September
- Point of Sale (POS) Blackout Period on 9/21/2019
June
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period
- Vermont Medicaid Co-Pay Clarification - Pharmacy - June 17, 2019
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period - June 12, 2019
May
April
- 340B Claims Submission at Point of Sale (POS) for Pharmacies enrolled in the Vermont Medicaid 340B Program
- Important Changes to Sildenafil Coverage
- Important Changes to Coverage for Brand and Generic Formulations of Retin-A (tretinoin) and Differin (adapalene)
February
January
2018
December
- Pharmacy Benefit Update Newsletter - Preferred Drug List (PDL); Effective 1/1/19
- Hematopoietics: Colony Stimulating Factors - Effective 1/1/19
November
October
- Important Changes to Coverage for Actavis (Labeler 00591) Authorized Generic of Concerta** - Effective 1/1/19
- Synagis 2018/2019 Season - Prior Authorization
- Notice of Legislative Changes Affecting Medicaid
- Changes to Suboxone Film Prior Authorization Requirements Effective October 12th
September
August
July
- Important Changes to Coverage for Adderall and Generic Amphetamine/Dextroamphetatmine ER capsules
- Point of Sale (POS) Blackout Period Wednesday July 11th, 2018
May
April
- Important Changes to Coverage for Concentra and Actavis (Labeler 00591) Authorized Generic
- eWEBS Pharmacy Provider Portal - DVHA's new pharmacy benefits program
January
2017
December
- Naloxone - 2 preferred products on the PDL not requiring prior authorization requirement
- Pharmacy Benefit Newsletter Update - 2018 PDL Changes
- Important Changes to Coverage for Strattera - Effective 1/1/18
- Combivent and Respimat Moving to PA - Effective 1/1/18
- Important Changes to Coverage for Hepatitis C Agents - Effective 1/1/18
September
- Influenza 2017/2018 Season Updates
- Synagis 2017/2018 Season Updates
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period - Effective 9/23/2017
July
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period - Effective 7/19/2017
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period - Effective 7/19/2017
June
May
- Change Healthcare Common Helpdesk Questions
- POS System Testing on 5/17/2017
- Upcoming Preferred Drug List Changes - Effective 5/26/17
April
March
- IMPORTANT NOTICE: Point of Sale (POS) Blackout Period on 3/29/2017
- Frequently Asked Questions and Answers Related to the Pharmacy Reimbursement - Effective April 1, 2017
- Implementation of New Pharmacy Pricing Rules - Effective April 1, 2017
February
- HepC Criteria Changes 2/17/17 - Effective Immediately
- Survey of the Average Cost of Dispensing a Medicaid Prescription in the State of Vermont - February 08, 2017
- Contraceptive Days Supply Changes - 02/14/2017
January
- Fax Blast: Preferred Diabetic Supply List - Effective January 2017
- Pharmacy Benefit Update: PDL Changes - Effective 1/1/2017